The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators
Abstract
Alzheimer's disease (AD), characterized by the β-amyloid protein (Aβ) deposition and tau hyperphosphorylation, is the most common dementia with uncertain etiology. The clinical trials of Aβ monoclonal antibody drugs have almost failed, giving rise to great attention on the other etiologic hypothesis regarding AD such as metal ions dysmetabolism and chronic neuroinflammation. Mounting evidence revealed that the metal ions (iron, copper, and zinc) were dysregulated in the susceptible brain regions of AD patients, which was highly associated with Aβ deposition, tau hyperphosphorylation, neuronal loss, as well as neuroinflammation. Further studies uncovered that iron, copper and zinc could not only enhance the production of Aβ but also directly bind to Aβ and tau to promote their aggregations. In addition, the accumulation of iron and copper could respectively promote ferroptosis and cuproptosis. Therefore, the metal ion chelators were recognized as promising agents for treating AD. This review comprehensively summarized the effects of metal ions on the Aβ dynamics and tau phosphorylation in the progression of AD. Furthermore, taking chronic neuroinflammation contributes to the progression of AD, we also provided a summary of the mechanisms concerning metal ions on neuroinflammation and highlighted the metal ion chelators may be potential agents to alleviate neuroinflammation under the condition of AD. Nevertheless, more investigations regarding metal ions on neuroinflammation should be taken into practice, and the effects of metal ion chelators on neuroinflammation should gain more attention. Running title: Metal chelators against neuroinflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypothesis suggests that metal dyshomeostasis can lead to oxidative stress, which is linked to various pathological events in AD, such as amyloidosis and tauopathy.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [21]
In the citing paper
“The metal ion hypothesis examines the dysregulation of metal ions, particularly copper, zinc, and iron, which plays a significant role in the pathogenesis of AD.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [21]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedNIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Copper induces cell death by targeting lipoylated TCA cycle proteins
Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022) · Science · doi:10.1126/science.abf0529 · Cited by 4,932
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Research works printed but not linked: 10
- Petersen, 2018, Practice Guideline Update Summary: Mild Cognitive Impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology, Neurology, 90, 126
- Rajasekhar, 2018, Current Progress, Challenges and Future Prospects of Diagnostic and Therapeutic Interventions in Alzheimer's Disease, RSC Adv, 8, 23780
- Schrag, 2011, Iron, Zinc and Copper in the Alzheimer's Disease Brain: A Quantitative Meta-Analysis, Some Insight on the Influence of Citation Bias on Scientific Opinion, Prog Neurobiol, 94, 296
- Feng, 2020, Transferrin Receptor Is a Specific Ferroptosis Marker, Cell Rep, 30, 3411
- Syme, 2006, Solution 1h Nmr Investigation of Zn2+ and Cd2+ Binding to Amyloid-Beta Peptide (Abeta) of Alzheimer's Disease, BBA, 1764, 246
- Yang, 2005, Curcumin Inhibits Formation of Amyloid Beta Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo, J Biol Chem, 280, 5892
- Liu, 2010, Neuronal Lrp1 Knockout in Adult Mice Leads to Impaired Brain Lipid Metabolism and Progressive, Age-Dependent Synapse Loss and Neurodegeneration, J Neurosci, 30, 17068
- Jalili-Baleh, 2021, Chromone-Lipoic Acid Conjugate: Neuroprotective Agent Having Acceptable Butyrylcholinesterase Inhibition, Antioxidant and Copper-Chelation Activities, Daru, 29, 23
- Zhang, 2015, Amentoflavone Protects Hippocampal Neurons: Anti-Inflammatory, Antioxidative, and Antiapoptotic Effects, Neural Regen Res, 10, 1125
- Tian, 2020, Flurbiprofen-Chalcone Hybrid Mannich Base Derivatives as Balanced Multifunctional Agents against Alzheimer's Disease: Design, Synthesis and Biological Evaluation, Bioorg Chem, 94
Cited by
Sorted by citations
Items 101–200 of 200
Hu, R., Xiao, Z., Qiao, M., Liu, C., Wu, G., Wang, Y., Huang, Z., & Dong, M. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13318 · Cited by 6
“Cu 2+ overload promotes cuproptosis (12), and Cu 2+ and cuproptosis are closely related to mitochondrial functions (13,14).”
Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer’s Disease
Liu, Y., Zhang, Z., Zhu, Z., Yang, Y., Peng, W., Chen, Q., Mak, S., Tsim, K. W. K., & Pi, R. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575330648240819112435 · Cited by 6
Zheng, M., Chen, Z., Xie, J., Yang, Q., Mo, M., & Chen, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s515951 · Cited by 6
Self-citationKhan, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115283 · Cited by 8
“A β disrupts metal ion homeostasis in the brain by sequestering physiologically significant metal ions [131].”
Juarez-Romero, G. U., Sun, X., Gerez, J., Auwer, C. D., Landrot, G., Nachtegaal, M., Riek, R., Luo, J., & Quintanar, L. (2026) · Chemical Science · doi:10.1039/d5sc08604c · Cited by 7
“5,10,11 X-ray uorescence analysis has demonstrated the presence of both Cu and Zn in senile plaques of AD patients, 12 while metal accumulation has been correlated with A b deposits in AD transgenic murine models.”
Wang, X., Wang, B., Yang, F., Shang, K., Chen, S. W., & Zhang, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1353286 · Cited by 6
Xie, W., Chen, H., Shao, N., Zhang, X., Huang, C., Li, X., Zhang, J., Chang, Z., Tang, L., & Xie, D. (2024) · Current Neurovascular Research · doi:10.2174/0115672026348862241003042336 · Cited by 6
Modulation of Primary and Secondary Processes in Tau Fibril Formation by Salt-Induced Dynamics
Vahid, A. A., Hassan, M. S. O., Sahayaraj, A. E., Babu, A. T., Kizhakkeduth, S. T., & Vijayan, V. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00852 · Cited by 6
The emerging role of cuproptosis in spinal cord injury
Xu, D., Hu, L., Zhou, J., Deng, X., Zhu, Y., & Liu, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595852 · Cited by 5
Designing potential inhibitors for AChE from quinazoline derivatives
Thai, Q. M., Tran, P., Nguyen, T. K., Hung, N. V., Hiền, T. T. T., Tieu, P. V., Pham, N. Q. A., Tuyến, P. N. K., Nguyen, T. H., Pham, M. Q., et al. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143099 · Cited by 5
Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5
Radiolabeled imaging agents for Alzheimer's disease
Wu, J., Li, K., Yang, J., Mao, M., & Cheng, Y. (2023) · iRadiology · doi:10.1002/ird3.35 · Cited by 5
Yao, X., Wang, J., Liu, J., Yu, C., Jing Hua, H. U., Wang, X., Fu, J., & Yin, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117196 · Cited by 4
Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer’s disease
Zhong, Y., Deng, J.-Z., Wang, Q., Chen, L. B., Yang, Z., Zhang, Y., Zhou, L., Li, Y., Wu, J., & Wang, X. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11129-2 · Cited by 5
Self-citationThe Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease
Tang, L., Liu, F., Sun, X., Yang, J., Liu, Y., Pan, X., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04160-7 · Cited by 5
Li, W., Guo, Q., Li, X., Huang, L., Liu, H., & Liu, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s561184 · Cited by 4
“14 In the nervous system, copper homeostasis imbalance is closely related to Alzheimer’s disease 15 and Parkinson’s disease.”
Khattab, N. A., El-Kadem, A. H., Goda, A. E., El‐Mahdy, N. A., & El‐Shitany, N. A. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115814 · Cited by 4
Zhang, Y., Cai, R., Ding, Y., Zhang, J., Ning, C., Zeng, J., Zhou, Z., Wang, S., Li, Y., & Guo, X. (2024) · Smart Molecules · doi:10.1002/smo.20240048 · Cited by 4
Sun, R., Xiao, Q., Long, H., Dang, R., Zhao, S., Guo, J., Chu, X., Sun, H., Zhang, Y., & Jiang, P. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s531720 · Cited by 5
Ni, W., Ding, J., Gong, P., Tan, X., & Li, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105936 · Cited by 4
da Silva, A. F., Gomes, A., Gonçalves, L., Fernandes, A. M. A., & Almeida, A. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020141 · Cited by 4
“…spectrum of clinical outcomes and pathological events associated with the disease continuum, alternative hypotheses have emerged (e.g., the mitochondrial cascade hypothesis [34], the vascular hypothesis [35], the metal ion hypothesis [36], the oxidative stress hypothesis [37], and others [38,39]).”
Synthesis and Characterization of Thiazole Derivatives as Cholinesterase Inhibitors
Zhang, Z., Han, S., Mingyu, W., Zien, Y., Hu, P., He, R., Cao, Y., & Shi, D. (2025) · ChemistrySelect · doi:10.1002/slct.202500051 · Cited by 4
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
Kola, A., Quéméré, N., Gadais, C., & Valensin, D. (2025) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2025.112973 · Cited by 2
Karki, A., Nawani, A., Sharma, S., Poddar, D., & Singh, A. (2025) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2025.2558051 · Cited by 3
Huang, T., Xu, J., Liang, C., Gong, L., & Ling, X. (2024) · The Analyst · doi:10.1039/d4an01176g · Cited by 3
Kolay, A., & Kumar, A. (2024) · Talanta · doi:10.1016/j.talanta.2024.127438 · Cited by 3
Dabaghian, F., Delnavazi, M., Hariri, R., Akbarzadeh, T., Tayarani‐Najaran, Z., Ardekani, M. R. S., Sharifzadeh, M. S., & Khanavi, M. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04902-1 · Cited by 3
Cao, T. H. M., Le, A. P. H., Tran, T. T., Huynh, V. K., Pham, B. H., Le, T., Nguyen, Q. L., Tran, T. C., Tong, T. M., Than, T. H. N., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1308610 · Cited by 3
Bee Pollen Potential to Modulate Ferroptosis: Phytochemical Insights for Age-Related Diseases
Kacemi, R., & Campos, M. G. (2025) · Antioxidants · doi:10.3390/antiox14030265 · Cited by 3
“…high levels in AD and PD patient brains and was shown to alter BBB integrity, drive mitochondrial and neuronal damage and death, be tightly linked to aberrant protein deposition and neuroinflammation, and possibly be involved in the neurodegenerative process as early as its early stages [212,229].”
Computer-aided Drug Design for Alzheimer's Disease: Recent Advancements and Future Perspectives
Rohilla, S., & Goyal, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266343814250713100224 · Cited by 2
Yang, Y., Ren, Q., Liu, D., Zhu, Y., Zhang, S., & Zhang, M. (2025) · ACS Applied Electronic Materials · doi:10.1021/acsaelm.5c01303 · Cited by 2
Liu, Y.-T., Zhang, Q.-Q., Yao, S.-Y., Jiang, Z., Cui, H.-W., Wang, H., Wang, Y.-Y., Shen, F.-Q., Zou, Y., & Zhao, L.-X. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115881 · Cited by 3
Self-citationLycium barbarum glycopeptide protects neurons from amyloid-beta toxicity
Chen, Z., Wang, X., Wang, S., Wu, Z., Wang, H., Chiu, K., Zheng, X., & So, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00501 · Cited by 2
“There are several hypotheses regarding the pathogenesis of AD, including the amyloid cascade (Kepp et al., 2023), tau protein (Zheng et al., 2024), inflammation (Hanslik and Ulland 2020), metal ion (Chen et al. 2023), and oxidative stress hypotheses (Bai et al., 2022).”
Influence of Rosmarinic Acid on Zinc(II)–Amyloid Beta Coordination
Kola, A., & Valensin, D. (2025) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202500334 · Cited by 2
Yang, F., Chen, Y., Yan, Y., Zhao, R., Deng, L., Tian, D., & Xie, M. (2026) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2026.115464 · Cited by 1
The aggregation of amyloid-β: from condensation, nucleation, and conformation to targeting therapy
Chen, B., Chen, T., Sun, Z., Liu, L., Jia, Y., Ji, Y., Wang, J., Sun, F., & Huang, Y. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124397 · Cited by 2
Du, W., Wu, T., Fan, Y., & Zhao, M. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00808 · Cited by 3
Self-citationKumar, N., khan, I., Singh, J., Kumar, K., Kushwaha, V. K., Ojha, S., Raman, S. K., & Shankar, G. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110361 · Cited by 2
Zhao, L., Li, B., & Zheng, L. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401548 · Cited by 2
Self-citationTherapeutic approaches in proteinopathies
Nabi‐Afjadi, M., Dabirmanesh, B., & Uversky, V. N. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.008 · Cited by 2
Liang, J., Wang, Y., Liu, B., Dong, X., Cai, W., Zhang, N., & Zhang, H. (2023) · doi:10.22541/au.169753470.03178440/v1 · Cited by 2
Essential trace metals in health and disease
Makević, V., Luka, S. R. D., & Ilić, A. Ž. (2023) · Medicinski podmladak · doi:10.5937/mp74-43573 · Cited by 1
Jaipuria, A., Castillo, M., Boksanski, J., Landry, G. M., Beak, J. H., Young, M., Priefer, D. T., Guessab, K., Ellis, C. N., & Priefer, R. (2024) · Chemistry · doi:10.3390/chemistry6060089 · Cited by 1
Hurdles and Strategies in Treating Alzheimer’s Disease
Qureshi, T., Desale, S. E., Chidambaram, H., & Chinnathambi, S. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_6 · Cited by 1
Elemental Imbalances After Manganese Exposure and the Regulatory Potential of Curcumin
Zhao, H. Y., Zeng, J.-M., Li, Y., Ao, C.-Y., Liu, D., Zhuo, J.-P., Yu, C. W., Ban, J.-Q., & Li, J. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04586-1 · Cited by 1
“Current therapies for metal overload focus primarily on chelating agents, which often lead to side effects and reduced quality of life [46, 47].”
Discrimination of alkaline earth metals and transition metals using CD/CPL spectroscopy
Zhao, Y., Hu, X., Yang, J., Zhao, J., & Liu, M. (2025) · Surfaces and Interfaces · doi:10.1016/j.surfin.2025.106940 · Cited by 1
Tolbatov, I., Marzo, T., Peana, M., Medici, S., Zoroddu, M. A., Mendola, D. L., & Marrone, A. (2025) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2025.112979 · Cited by 1
Zhu, X., Ma, J., Guo, C., Hopke, P. K., Tian, Y., Li, Q., Wei, Y., & Zhang, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119004 · Cited by 1
Stelmashook, E. V., Генрихс, Е. Е., Alexandrova, O. P., Lapieva, A. E., Рафаилевна, К. М., & Исаев, Н. К. (2025) · Biomeditsinskaya Khimiya · doi:10.18097/pbmcr1597 · Cited by 1
Novel Schiff base-Pt( ii ) complexes: inhibition of Aβ aggregation via histidine interaction
İrişli, S., Doğan, U., Günnaz, S., Yurt, F., & Şahin, O. (2025) · New Journal of Chemistry · doi:10.1039/d5nj04180e · Cited by 1
Franco, D. P., Caruso, L., Grillo, D. C. N., Nadur, N. F., de Azevedo, L. L., Pereira, T. M., da Silva, M. C., Lacerda, R. B., Pinheiro, P. D. S. M., Riger, C. J., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c09002 · Cited by 1
Jin, Y., Lu, K., & Yang, Y. (2026) · Antioxidants · doi:10.3390/antiox15030353 · Cited by 1
“Alzheimer’s Disease (AD) Amyloid-β (A β )/Cu complex-induced A β deposition [54] Tau hyperphosphorylation/aggregation [55] Cu-activated microglial NF-κ B signaling [54] Parkinson’s Disease (PD) Cu-induced α -synuclein aggregation and Lewy body formation [55] Reduced nigral copper increases…”
Zhang, L., Zhou, X., Wu, J., Wang, H., Zhang, A., Shen, R., Yang, A., & Kou, X. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.145940 · Cited by 1
Folarin, R. O., Olopade, F. E., Gilbert, T. T., Ladagu, A. D., dos Santos, P. I. P., Mustapha, O., Kpasham, L. Z., Outeiro, T. F., & Olopade, J. O. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01811-1 · Cited by 1
Chauhan, P., Wadhwa, K., Sachdeva, H., & Singh, G. (2026) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2026.53202 · Cited by 1
Liu, X., Xu, J., Lin, C., Gao, X., Xie, Y., Chen, X., Huang, Q., Ye, R., Shi, H., Zhang, L., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109887 · Cited by 1
Nanotheranostics for Alzheimer’s Disease: The Rising Promise of Fluorescent Carbon Dots
Prasad, G., Srivastava, M., & Singh, V. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00290 · Cited by 1
Oligomerization and aggregation of NAP-22 with several metal ions
Maekawa, S., Yuzu, K., Chatani, E., & Morigaki, K. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137623 · Cited by 1
Lakela, A. L., Berntsson, E., Vosough, F., Jarvet, J., Paul, S., Barth, A., Gräslund, A., Roos, P. M., & Wärmländer, S. K. T. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3697127/v1
Controlo de Biometais no Contexto de Fármacos Multifuncionais para a Doença de Alzheimer
Santos, M. A., & Chaves, S. (2024) · Boletim da Sociedade Portuguesa de Química · doi:10.52590/m3.p708.a30002748
Addo, A., Li, B., Murikinati, S. R., Gardner, R., & Zhao, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.10.653288
Self-citationMechanistic Understanding of the Anti-Alzheimer’s Agents with Computational Studies
Joshi, N., Chobe, S., G., S. N. K. R., & Alavala, R. R. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_20
Yang, T. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04570-0
“Current pathogenic para - digms emphasize Aβ plaque formation [ 19, 20], tau protein hyperphosphorylation [21, 22 ], and microglia-mediated neuroinflammatory cascades [ 23, 24].”
Novel benzylpiperidine -derived acetylcholinesterase inhibitors with antioxidant properties
Zuo, J., Liu, A., Wang, H., Chen, W., & Jiang, X. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144346
Changes in quantitative magnetic resonance imaging susceptibility mapping in Alzheimer's disease
Dolgushin, M. B., Martynov, M. Y., Валерьевич, Д. А., Kuznetsov, A. A., Bogolepova, A. N., Sashin, D., Валерьевич, Н. Р., & Tairova, R. T. (2025) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2025-5-21-28
Sun, Y., Jiang, X., Yi, X., Wang, C., Zhang, X., Shen, R., Yang, A., & Kou, X. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202501827 · Cited by 1
Identification and validation of PANoptosis-related genes in Alzheimer's disease
Zhou, W., Lin, H., Huang, X., & Zhou, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251396927
“3,4 Currently, it is widely recognized that A β is abnormally deposited in the extracellular compartment to form amyloid plaques, which not only leads to mitochondrial axonal transport disorders and synaptic damage, but also induces abnormal phosphorylation of intracellular tau proteins to form…”
Lyu, K., Chen, Q.-Y., Liu, J.-J., Ding, H., Chen, F., & Wang, G. (2026) · New Journal of Chemistry · doi:10.1039/d5nj03638k
Zhou, X., Zhang, Y., Sun, L., Kwok, C. K., & Zhang, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700564
“Indeed, genes controlling ion homeostasis were dysregulated in AD patients, consistent with existing reports on ion imbalance, with many of the affected genes regulating zinc, copper, and calcium homeostasis 47 .”
Güngör, B., Kılıç, B., & Doğruer, D. S. (2025) · EMU Journal of Pharmaceutical Sciences · doi:10.54994/emujpharmsci.1834518
Masloub, J. A., & Avalon, N. E. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c01562
Zhang, J., Li, Y., Li, Y.-P., Xun, Q., Ma, Y., & Shi, X.-L. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109760
Inhibition of d-ribose-induced glycation of metalloprotein human myoglobin by bioactive quinones
Liu, J.-J., Miao, S.-D., Wang, Z., Zhu, Y.-H., Jiang, B.-B., Long, S.-S., Gao, S., & Lin, Y. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.127817
Self-citationZhou, X., Wan, J., Lv, N., Ma, R., & Liu, W. (2026) · BMC Medical Research Methodology · doi:10.1186/s12874-026-02851-y
“Metal chelators might affect AD in the following mechanism: Iron, copper and zinc could both enhance the production of Abeta and directly bind to Abeta and tau to promote aggregations, and moreover the accumulation of iron and copper could respectively promote ferroptosis and cuproptosis [49].”
Chang, W., Chen, Y., Kan, J., Huang, X., & Luo, K. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71702
Ferroptosis-immune crosstalk in CNS diseases: mechanisms and translational insights
Li, L., Wang, S., Duan, L., Zhang, L., Yan, H., Chen, X., Tao, L., & Gao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1807104 · Cited by 1
“Ferroptosis not only functions as an effector of neuronal and tumor cell death but also regulates immune cell activation, differentiation, and polarization, while immune-derived signals reciprocally shape ferroptosis susceptibility (13, 14).”
Singh, K., Priyadarshi, N., Goyal, B., Singhal, N. K., & Goyal, D. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00649
Lee, J., Hong, E., Na, C., Li, Y., Go, J., Kim, J.-E., Seo, H.-H., Suh, J., Kwak, J., Lee, Y., et al. (2026) · Small · doi:10.1002/smll.74013
“Hallmark pathological features, including amyloid-β (A β ) aggregate accumulation [26–28] and metal ion dyshome-ostasis [15, 29–31], exacerbate oxidative damage and contribute to neuronal death.”
Wang, S., Wu, Y., Li, J., Xu, B., Shan, D., & Huang, J. (2026) · Microchimica Acta · doi:10.1007/s00604-026-08169-2
Research progress of ferroptosis in gynecological diseases
Chen, W., Zhou, W., & Liu, S. (2026) · Annals medicus · doi:10.1080/07853890.2026.2688328
“…in slowing the neurodegenerative progression of Alzheimer’s Disease (AD) by chelating abnormally deposited iron ions in the brain, inhibiting oxidative stress responses, and reducing pathological protein accumulation, thereby offering a novel therapeutic strategy for AD intervention [317–321].”
Hydroperoxides: Plant Steroids and Triterpenoids as Promising Candidates for Anti-Dementia Therapy
Dembitsky, V. M., & Terent'ev, A. O. (2026) · Oxygen · doi:10.3390/oxygen6030015
“It emphasizes that while some of these metals are essential for normal brain function, their dysregulation can lead to harmful effects such as oxidative stress, protein aggregation, and impaired synaptic signaling [128,129].”
An Overview of Dementia and Alzheimer's
Trivedi, R., Maheshwari, R. A., Patel, K. P., Bhandari, S., Hadia, R., Goyal, S., & Soni, R. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815523126010005
Yang, F., Chen, Y., Yan, Y., Zhao, R., Deng, L., Tian, D., Wang, Q., & Xie, M. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.141133
Geraiely, B., Kianmehr, E., Iraji, A., Bukhari, S. N. A., Mohammadi, H., Mojtabavi, S., Mahdavi, M. R., & Saeedi, M. (2026) · RSC Advances · doi:10.1039/d6ra04932j
Kumar, N., & Yarlagadda, V. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00255
Neurotoxic Metals and Metal Homeostasis in the Brain
Alabi, T. O., Apanisile, O. L., Akinpelu, F. O., Ojo, A., Yakub, A. D., Kolo, R. M., Babalola, A. V., Abdulraheem, M. T., & Ajayi, F. E. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-1403-5.ch001
Rationally Designed Peptides and Peptoids as Inhibitors of Amyloid-β (Aβ) Aggregation
Huang, X., Ma, S., Li, X., & Pan, J. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00145
Milardi, D., Han, J., Lee, H. J., Ding, F., Miller, Y., Faller, P., Bush, A. I., Crouch, P. J., Finkelstein, D. I., Double, K. L., et al. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00420
Cuproptosis in Ischemic Stroke: Molecular Mechanisms and Therapeutic Potential
Han, X., Zhang, W., An, H., Zhang, J., Tian, J., & Wang, Y. (2026) · Molecules · doi:10.3390/molecules31183351
“Their mechanisms of action involve multiple signaling pathways, demonstrating neuroprotective potential in the treatment of neurodegenerative and other neurological disorders [88].”
Paparella, M., Leuci, R., Cerini, M., Simić, S., Chaves, S., Carrieri, A., Loiodice, F., Tortorella, P., Laghezza, A., Wackerlig, J., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110599
Pereira, M. V. D. S., Alfredo, L. H. M., de Moraes, M. N., & de Jesus, J. R. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.08.004
Addo, A., Li, B., Murikinati, S. R., Gardner, R., & Zhao, L.-R. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1705436
Self-citationYuqi, L., & Gu, J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1925934
Noor, K., Alam, M. N.-E., Larguech, S., Alenezi, A. M., Alawad, M. A., Mahmood, M., Misran, N. B., Bais, B. B., & Islam, M. T. (2026) · Materials Today Communications · doi:10.1016/j.mtcomm.2026.116342
Qin, Q., Yan, Q., Zhu, K., Miao, J., Yang, M., Wu, Z., Fan, C., Jiang, P., Wu, G., & Wang, Q. (2026) · Molecules · doi:10.3390/molecules31203681
“However, recent studies indicate that glial cell dysfunction [8], gut–brain axis imbalances [9], disorders of brain metal ion homeostasis [10], and other mechanisms play non-negligible roles in AD.”
Yang, J., Lou, F., Sun, W., Li, M., Su, L., Wang, Y., 李平安, & Su, J. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109690
Mankoo, O. K., Priyadarshi, N., Singh, P. P., Goyal, B., Singhal, N. K., & Goyal, D. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp01611a
BindingDB (2026) · UC San Diego · doi:10.7270/q2w66rnn
Hao, M., Wu, D., Sun, L., Lai, X., 陈若虹, Zhang, Z., Li, Q., Zhang, S., Zheng, X., Li, D., et al. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c10083
Metadata
- Authors
- Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y.
- Affiliations
- China Medical University (CN)
- Corresponding author
- Wang, Zhan-You
- Venue
- Bioorganic Chemistry
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 131
- Pages
- 106301
- ISSN
- 0045-2068 (ISSN-L)
- OpenAlex
- W4310077403
- Cited by
- 200
- References
- 258
- Citations by year
- 2026: 45 · 2025: 65 · 2024: 60 · 2023: 30
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Bioorganic Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82001162, 92049106)
- Natural Science Foundation of Liaoning Province (LJKZ0736)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, iron, copper, zinc, metal chelators, neuroinflammation, amyloid-beta, tau hyperphosphorylation, ferroptosis, cuproptosis, amyloid fibril formation
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Chelating Agents, Copper, Humans, Ions, Iron, Metals, Zinc, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
